 The roles of immunodeficiency and combined antiretroviral therapy ( cART) in shaping the gut microbiota in HIV-1-infected subjects ( HISs) have not been described thoroughly by time-series investigations. In this study , 36 antiretroviral-naïve HISs were enrolled to prospectively assess alterations in the fecal microbiota and plasma markers of microbial translocation and inflammation<symptom> with cART. At baseline , the species α-diversity of the fecal microbiota was significantly lower in HISs with a CD4